All systems operational
Q3 2022

GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis

Mohammed Abdalla Rakha · Asmaa Ali · Waleed Hassan · Eman Al-Anbay
10.1186/s43168-022-00171-5 390 Views 2 Citations
2
Citations
390
Views
Abstract

AbstractPurposeThe aim of the study is to assess the diagnostic utility of bronchoalveolar lavage (BAL) samples with GeneXpert test in diagnosis of TB in smear-negative patients.MethodOne-hundred sixty-nine cases were included in this study, as they had a radiological finding suggested to have pulmonary tuberculosis, while the sputum direct smear examination for acid-fast bacilli was negative. All cases prepared to do fiber-optic bronchoscope with bronchoalveolar lavage collection after their consent and post bronchoscope sputum collection for further molecular and microbiological examination.ResultsThe combined diagnostic yield of all bronchoscopy procedures was 15.97% (27 cases of 169) and the final diagnosis of TB cases was established in 16 cases of 169 (9.4%) using BAL culture and in 20 cases of 169 (11.83%) by GeneXpert methods. Post bronchoscope direct sputum examination, culture, and GeneXpert evaluation gave diagnostic yield about 1.1%, 5.5%, and 7.1%, respectively. The specificity of GeneXpert examination of BAL and post bronchoscope sputum was 95.42% and 97.38%, respectively.ConclusionEarly detection of pulmonary tuberculosis using fiber-optic bronchoscope BAL examination and post bronchoscope sputum with GeneXpert method promotes the accurate decision to start antituberculous therapy in patients with smear negative.

Cite this Article (APA)
Mohammed, A. R., Asmaa, A., Waleed, H., Eman, A. (2022). GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis. Egyptian Journal of Bronchology. https://doi.org/10.1186/s43168-022-00171-5
Related Papers
Criteria and potential predictors of severity in patients with COVID-19
Niveen E. Zayed; Ahmad Abbas; Samah Mohamad Lutfy · 2022
24
cites
390
Serum interleukin-6 in chronic obstructive pulmonary disease patients and its relation to severity a…
Fatma G. M. Hussein; Randa S. Mohammed; Rasha A. Khattab; Laila A. Al-Sharawy · 2022
24
cites
390
Predictors of severity and mortality in COVID-19 patients
Hebatallah Hany Assal; Hoda M. Abdel-hamid; Sally Magdy; Maged Salah; Asmaa Ali; · 2022
19
cites
388
Protective mechanism of quercetin and its derivatives in viral-induced respiratory illnesses
Wahyu Choirur Rizky; Muhammad Candragupta Jihwaprani; Mazhar Mushtaq · 2022
10
cites
391
Access
View Full Text via DOI
Published in
ISSN 1687-8426
Quartile Q3
AMS Score 82
Field Medicine & Health Sciences
Publisher Springer (Biomed Central Ltd.)
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2022
Language English
Added 14 Aug 2026